View Clinical Trial (Medical Research Study)

A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab - NCT00808210-53406(Clinical Trial 259520)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Racine
State:  
WI
Zip Code: 53406
Conditions: Rheumatoid Arthritis
Purpose: This is a Phase II, randomized, active-controlled, double-blind, double-dummy, parallel-group, multicenter study in the United States enrolling patients with active RA. The study will enroll approximately 290 patients at approximately 130 sites.
Study summary:
Criteria: Inclusion Criteria: - Age ≥ 18 years - Current treatment for RA on an outpatient basis - Active disease - Currently receiving 50 mg etanercept subcutaneously (SC) every week or 40 mg adalimumab SC every other week. - Considered by Investigator to be a primary non-responder to their first anti-TNFα treatment for efficacy reasons Exclusion Criteria: - Rheumatic autoimmune disease other than RA, or significant systemic involvement secondary to RA - History of, or current, inflammatory joint disease other than RA (e.g., gout, reactive arthritis, psoriatic arthritis, seronegative spondyloarthropathy, Lyme disease) or other systemic autoimmune disorder (e.g., systemic lupus erythematosus, inflammatory bowel disease, scleroderma, inflammatory myopathy, mixed connective tissue disease or other overlap syndrome) - Previous treatment with a any biologic therapy for RA (including investigational products with the exception of etanercept or adalimumab - Treatment with more than one prior anti-TNFα therapy
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: February 16, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.